Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
about
Repurposing metformin for cancer treatment: current clinical studiesPrognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma.Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityStem memory T cells (TSCM)-their role in cancer and HIV immunotherapiesMurine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasisTumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.The impact of inflammatory cells in malignant ascites on small intestinal ICCs' morphology and functionApigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.The diverse roles of the TNF axis in cancer progression and metastasis.Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?Could mycobacterial Hsp70-containing fusion protein lead the way to an affordable therapeutic cancer vaccine?Abscopal Effects and Yttrium-90 Radioembolization.MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES.Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation.IL-10: Expanding the Immune Oncology Horizon.Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors.Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer.Tumor-derived exosomes induce CD8+ T cell suppressors.Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer.Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IUnderstanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry.Description of the immune microenvironment of chondrosarcoma and contribution to progression.Non-coding RNAs profiling in head and neck cancers.Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.Inhibition of PI4K IIIα radiosensitizes in human tumor xenograft and immune-competent syngeneic murine tumor model.The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.NF-kappaB: Two Sides of the Same Coin.Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain.Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model.Overview of Basic Immunology for Clinical Investigators.
P2860
Q26752651-DFE00D93-142C-4B2C-A527-648DE3715119Q27332109-EC33B3D1-8F06-4F7D-AF1A-838383EE0CF5Q28387629-EFE32EB2-86B1-4A77-8414-D4991B358104Q34511615-660C5241-F41E-48DF-909B-B0C8B37AF2F0Q35023580-B0579880-0609-4603-B656-39AE14285326Q35169807-6F7ED375-8605-47BE-903A-7F3FD894E3BEQ36057470-3F2662BB-5A37-4A26-9323-A735ACA37A77Q36267629-F2ECF2BC-F3DF-4D28-9EE0-EA95B988A93EQ37474735-904CB281-B2CB-40C7-AFE6-6548B0F582B3Q37645095-6D194CEC-2553-4E57-8087-D7A67A42C62BQ38286381-48CC6963-F3C5-4895-9AA5-1EB63CDB8DB6Q38667899-BAC56287-C273-4FFB-84DC-DA5E97A1B3D7Q38671001-0D756844-84EA-4409-B361-E750408BF545Q38683494-6F5FA24D-D37C-41D5-A032-7F690625C01BQ38714704-A0BC1D8B-E6B4-47DC-9BD8-DEA366BAE85FQ38852674-DE1FBA94-2F7A-47BD-BDCD-874AD670CF74Q38873974-E1C19122-8A70-42C6-8227-8B402524B317Q38959382-8248D5E9-E709-4A5D-91D4-7A0024D634FBQ39425138-7ABD285D-387D-48A8-8FB1-13ABA03CC911Q40086525-DE0B23C2-6893-4C43-AF74-7BB7ADB3C7D4Q40160482-E6F59A8E-2B13-4628-A862-FD54E360350FQ40217856-32F068A4-6FC6-4280-AF82-BC45E50E3721Q40219738-7A676810-00BC-48BD-BF6F-5FF72430272EQ40568414-B99D95E3-A9FF-4264-83A2-C81B1CD223B0Q41392250-1DC9C4C9-64B5-487E-B563-4594FB8ABFA7Q41810793-FDDDD3EB-C301-4D17-B8AE-A6E6C6C92476Q41866420-9C9C8FD2-D185-4F1F-9F7B-E5FAB73E0938Q42376660-4527B582-61DC-4C65-AD3B-59FF59CD8958Q46532764-6D7A23CD-8315-4E47-BA6A-B8D8E75CEEB5Q47096307-096C82E2-6970-4DDF-B9FF-53DD6DDD1FC9Q47134263-E18F0BDF-7F37-4668-B366-BE34ABA1B9A9Q47153501-B32E4EA8-D551-4454-A3C8-9BEA77B3E28FQ47320798-7BA1BBA8-4CBC-43AB-97A2-2B478E1F65BCQ47556651-01F45F85-641B-44D0-B751-7F47E812D42AQ48529729-832609D6-5810-48C0-906E-728BE01972DBQ49461096-F1B95791-BFB8-4015-B607-7496AC9A764FQ50042871-521E4BBC-56EA-46A7-8E1D-971F307E34A8Q50175409-D7893C38-05EB-4C1F-B485-BBDDAD550EA0Q51795679-B3CE89FD-31A3-423E-AE6D-37A95D0944BFQ52699143-FE8896ED-AF2D-45E1-A8CA-92C5BCBAF895
P2860
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@en
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@nl
type
label
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@en
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@nl
prefLabel
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@en
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@nl
P2860
P50
P1433
P1476
Effector CD4 and CD8 T cells and their role in the tumor microenvironment.
@en
P2860
P2888
P304
P356
10.1007/S12307-012-0127-6
P577
2012-12-16T00:00:00Z